Computationally hybridized pathogenic mammarenavirus receptor binding domains reveal cryptic variants that elicit cross-neutralizing immune responses.

The pathogenic mammarenaviruses, Machupo (MACV) and Junin (JUNV), are under evolutionary pressure to leverage human transferrin receptor 1 (hTfR1) for cellular entry while evading host immune responses during zoonosis. We now structurally and functionally investigate cryptic, computationally hybridized JUNV-MACV GP1 sequence variants. We then evaluate the ability of those variants to facilitate internalization of pseudotyped virus-like particles (PVs) into human cells and their recognition by neutralizing antibodies, including plasma from JUNV convalescent patients. We further compare the cryoEM structures of hTfR1-bound MACV GP1 to those of two functional hTfR1-bound MACV-JUNV hybrid GP1 variants that enable robust PV internalization and are also recognized by cross-neutralizing antibodies. Immunization with these variants demonstrates they and other hybrid GP1 sequences can elicit cross-reactive, neutralizing antibodies, supporting a model in which sequence adaptation within GP1 balances receptor recognition with immune evasion. This may inform the rational design of broadly neutralizing GP1-targeted antiviral therapies.